Gene expression time-series analysis of Camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines

BACKGROUND: The clinical efficacy of camptothecin (CPT), a drug specifically targeting topoisomerase I (TopoI), is under evaluation for the treatment of malignant gliomas. Due to the high unresponsiveness of these tumours to chemotherapy, it would be very important to study the signalling network th...

Descripción completa

Detalles Bibliográficos
Autores principales: Morandi, Elena, Severini, Cinzia, Quercioli, Daniele, D'Ario, Giovanni, Perdichizzi, Stefania, Capri, Miriam, Farruggia, Giovanna, Mascolo, Maria Grazia, Horn, Wolfango, Vaccari, Monica, Serra, Roberto, Colacci, Annamaria, Silingardi, Paola
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556695/
https://www.ncbi.nlm.nih.gov/pubmed/18694480
http://dx.doi.org/10.1186/1476-4598-7-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556695/
https://www.ncbi.nlm.nih.gov/pubmed/18694480
http://dx.doi.org/10.1186/1476-4598-7-66

Ejemplares similares